Matthew Marc Cooper, M.D.
NPI 1811952716ActiveIndividual· Thoracic Surgery (Cardiothoracic Vascular Surgery)· Tulsa, OK
Thoracic Surgery (Cardiothoracic Vascular Surgery) (M.D.) in Tulsa, Oklahoma, licensed in NV, with an NPI issued in April 2006. Csl Plasma Inc. was the largest of 2 companies reporting payments in 2025, $225,089 in all, mostly consulting fees.
Overview
| NPI | 1811952716 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 20, 2006 |
| Last updated in NPPES | Apr 1, 2009 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Thoracic Surgery (Cardiothoracic Vascular Surgery) Primary | 208G00000X | 7037 | NV |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$225,089 · 59 payments from 2 companies
- 2024$218,459 · 54 payments from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Csl Plasma Inc. | $219,839 | 58 |
| Novartis Pharmaceuticals Corporation | $5,250 | 1 |
What the 2025 payments were for
- Consulting Fee$225,089 · 59 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Thoracic Surgery (Cardiothoracic Vascular Surgery) providers in Tulsa
- 1043309628
- 1902262421
- 1962510438
- 1629386529
- 1073942975
- 1023043577
- 1487036604
- 1245390863
- 1043666035
- 1235208042
- 1831124387
- 1740215292
All Thoracic Surgery (Cardiothoracic Vascular Surgery) providers in Oklahoma →